Showing results (161-170 of 222) with videos related to

Sort By:
Pageof 23
HIV Medicine|May 16, 2018
Diagnostic accuracy of new and old cognitive screening tools for HIV-associated neurocognitive disordersM Trunfio, D Vai, C Montrucchio, et al.
Infection|December 3, 2011
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot studyS Bonora, A Calcagno, C Cometto, et al.
The Journal of Infectious Diseases|October 23, 1997
Clinical cryptosporidiosis and human immunodeficiency virus (HIV)-induced immunosuppression: findings from a longitudinal study of HIV-positive and HIV-negative former injection drug usersE Pozio, G Rezza, A Boschini, et al.
Archives of Internal Medicine|March 11, 1996
Stereotactic brain biopsy in human immunodeficiency virus-infected patientsR Luzzati, S Ferrari, A Nicolato, et al.
Annals of Tropical Medicine and Parasitology|February 14, 2012
Prevalence of Strongyloides stercoralis infection among HIV-positive immigrants attending two Italian hospitals, from 2000 to 2009M Mascarello, F Gobbi, A Angheben, et al.
Lancet (London, England)|July 18, 1987
Prospective study of cellular immunity to hepatitis-B-virus antigens from the early incubation phase of acute hepatitis BS Vento, E G Rondanelli, S Ranieri, et al.
Journal of Neurovirology|January 19, 2022
Correlations between cerebrospinal fluid biomarkers, neurocognitive tests, and resting-state electroencephalography (rsEEG) in patients with HIV-associated neurocognitive disordersA Barco, S Orlando, G Stroffolini, et al.
The Journal of Antimicrobial Chemotherapy|July 16, 2015
Successful pharmacogenetics-based optimization of unboosted atazanavir plasma exposure in HIV-positive patients: a randomized, controlled, pilot study (the REYAGEN study)S Bonora, S Rusconi, A Calcagno, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 1, 1996
Community-acquired pneumonia in a cohort of former injection drug users with and without human immunodeficiency virus infection: incidence, etiologies, and clinical aspectsA Boschini, C Smacchia, M Di Fine, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2005
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical settingD González de Requena, S Bonora, S Garazzino, et al.
Pageof 23